Delivery Order SPE2DE24D0013-SPE2D626F12SF
- Not listed
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $1,277.84 to Cepheid Inc. (Sunnyvale, CA) on January 14, 2026, with an ultimate completion date of January 22, 2026. This firm fixed-price delivery order, which carries no set-aside designation, is issued under a larger indefinite delivery contract vehicle and represents a child contract action. Cepheid, a leading manufacturer of molecular diagnostic systems and reagents, provides the GeneXpert diagnostic...
- The Defense Logistics Agency Medical Supply Chain awarded a $6,800 firm fixed-price delivery order to Cepheid Inc. on December 8, 2025, with an ultimate completion date of December 15, 2025. This delivery order, designated XPRS4PLEX-10, represents a small procurement of diagnostic reagents and test kits for Cepheid's GeneXpert diagnostic platform. The contract carries no set-aside designation and is being performed at Cepheid's headquarters location in Sunnyvale, California. As a leading federal...
- The Defense Logistics Agency Medical Supply Chain awarded a $10,914 delivery order to Cepheid Inc. on December 17, 2025, for diagnostic testing supplies under the product line XPCOV2/FLU/RSV-10, with an ultimate completion date of January 2, 2026. This firm fixed-price delivery order, which includes no set-aside designation, will be performed at Cepheid's headquarters in Sunnyvale, California. The delivery order is part of Cepheid's established role as a primary federal supplier of molecular...
- The U.S. Defense Logistics Agency, operating under the Medical Supply Chain division, awarded a $5,520 firm fixed-price delivery order to Cepheid Inc. on August 20, 2025, with an ultimate completion date of August 27, 2025. This delivery order, designated XPRSTREPA-10, carries no set-aside designation and will be performed at Cepheid's facility in Sunnyvale, California. The contract represents a procurement of molecular diagnostic solutions from Cepheid, a specialized manufacturer of advanced...
- The Defense Logistics Agency Medical Supply Chain awarded a $13,600 firm fixed-price delivery order to Cepheid Inc. on November 4, 2025, with an ultimate completion date of November 12, 2025. The delivery order, designated XPCOV2/FLU/RSV-10, procures molecular diagnostic testing supplies and reagents for detecting COVID-19, influenza, and respiratory syncytial virus. Cepheid, headquartered in Sunnyvale, California, is a leading federal supplier of advanced molecular diagnostic systems and...
- The Department of Defense Medical Supply Chain (Defense Logistics Agency) awarded Cepheid Inc., a Sunnyvale, California-based molecular diagnostics manufacturer, a firm fixed-price delivery order valued at $27,863.40 on January 8, 2026. This delivery order, issued under the contract number 4570456612 (XPRS4PLEX-10), is a child award under a larger indefinite delivery vehicle and calls for diagnostic reagents and test kits for the GeneXpert diagnostic platform. The contract carries no set-aside...
- Cepheid Inc., a Sunnyvale, California-based manufacturer of advanced molecular diagnostic systems, was awarded a $2,024 firm fixed-price delivery order by the Defense Logistics Agency Medical Supply Chain on January 6, 2026, with an ultimate completion date of January 13, 2026. This delivery order, designated XPRSTREPA-10 (4570410034), carries no set-aside designation and represents procurement of diagnostic testing supplies and reagents from Cepheid's established federal product portfolio....
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $2,992 to Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic systems and reagents, on November 5, 2025, with an ultimate completion date of November 20, 2025. This firm fixed-price delivery order, designated XPCOV2/FLU/RSV-10, procures diagnostic supplies related to COVID-19, influenza, and respiratory syncytial virus testing. The contract carries no set-aside designation,...
- The Defense Logistics Agency Medical Supply Chain awarded Cepheid Inc., a leading molecular diagnostics manufacturer headquartered in Sunnyvale, California, a delivery order valued at $3,400 under contract XPRS4PLEX-10 on January 9, 2026. This firm fixed-price delivery order, with an ultimate completion date of January 16, 2026, is a child contract issued without set-aside designation and represents procurement of diagnostic testing supplies for federal healthcare operations. The award falls...
- The Defense Logistics Agency Medical Supply Chain awarded Cepheid Inc. a $10,000 firm fixed-price delivery order on November 24, 2025, for COVID-19, influenza, and respiratory syncytial virus diagnostic supplies. The delivery order, valued at the ceiling amount, is scheduled for completion by December 2, 2025, with performance taking place at Cepheid's headquarters in Sunnyvale, California. This delivery order carries no set-aside designation and represents a continuation of Cepheid's...
- SPE2DE24D0013Indefinite Delivery Contract
- SPE2DE24D0013-SPE2D626F12SFDelivery Order
The Defense Logistics Agency Medical Supply Chain has awarded a delivery order valued at $5,775 to Cepheid Inc. for diagnostic testing supplies under a larger indefinite delivery contract framework. This firm fixed-price delivery order, designated XPRS-COV2-10, was awarded on January 16, 2026, with an ultimate completion date of January 26, 2026, and is not subject to any small business set-aside designation. The order calls for delivery to Cepheid's headquarters location in Sunnyvale, California, and represents a continuation of the company's established role as a primary federal supplier of molecular diagnostic solutions, particularly COVID-19 testing cartridges and related reagents compatible with the GeneXpert diagnostic platform. Cepheid maintains extensive contracting relationships across multiple federal healthcare agencies, including the Department of Veterans Affairs, Indian Health Service, Defense Health Agency, and the U.S. Coast Guard, reflecting substantial federal reliance on the company's molecular diagnostic capabilities. The company's federal portfolio encompasses GeneXpert diagnostic systems, PCR test kits for infectious diseases including COVID-19, influenza, and respiratory syncytial virus, as well as maintenance and repair services. This delivery order aligns with the Defense Logistics Agency Medical Supply Chain's mission to support military medical operations and represents a modest procurement under the company's broader federal contracting portfolio, which includes indefinite delivery contracts valued at tens of millions of dollars extending through 2030.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.8k | 1/15/26 |